• Home
  • Contact Us
  • Try it!
  • Blog
  • Vizit Graphs

Follow us

Recent Posts

  • High Throughput Layout and Copy Paste July 5, 2019
  • Biovista in World’s Top 20 AI Drug Development Companies March 22, 2019
  • Biovista signs EU-IMI2 research agreement to advance neurotoxicity de-risking in preclinical drug discovery March 15, 2019
  • The increasing importance of predicting AEs & the role of Augmented Intelligence September 10, 2018
  • New Vizit Bibliography pane January 8, 2018

Biovista Vizit

Biovista Vizit

  • Try it!
  • Blog
  • Vizit Graphs

NIVOLUMAB

Immune checkpoint blockade in cancer immunotherapy

August 28, 2018Cancer, Cancer Immunotherapy, Vizit Graphs
Immune checkpoint blockade in cancer immunotherapy

Explore immune checkpoint blockade (PD-1, CTLA-4) in cancer immunotherapy with Biovista Vizit. Explore the live graph.

Vizit Graphs Tag Cloud

DIABETES MELLITUS ERBB-2 STREPTOCOCCUS PNEUMONIAE CANDIDA ALBICANS INSULIN ESCHERICHIA COLI CELL DEATH APOPTOTIC PROCESS IL23A METFORMIN CELL DIVISION AUTOPHAGY CTLA4 INFLAMMATION CELL DIFFERENTIATION RHEUMATOID ARTHRITIS PSEUDOMONAS AERUGINOSA TH17 CELLS REMICADE PORPHYROMONAS GINGIVALIS RECEPTOR CELL PROLIFERATION TP53 HELICOBACTER PYLORI IFNG BREAST CANCER NEURODEGENERATIVE DISORDERS DOXORUBICIN IMMUNE RESPONSE CLOSTRIDIUM DIFFICILE TNF SOD1 LISTERIA MONOCYTOGENES IL6 IL17A ANGIOGENESIS PARKINSON DISEASE FOXP3 STAPHYLOCOCCUS AUREUS CD4 CANCER ALZHEIMER'S DISEASE CASP3 AGING 1-METHYL-4-PHENYL-1-2-3-6-TETRAHYDROPYRIDINE

© 2019 Biovista Vizit All Rights Reserved.